Out of 20 miRNAs experimentally validated to control the expression of AKT1 whose constitutional activation drives the emergence of the NEPC phenotype, several miRNAs were reported to be specifically implicated in prostate cancer. The gene discussed is AKT1; the disease is prostate carcinoma.